<code id='95F59A12C1'></code><style id='95F59A12C1'></style>
    • <acronym id='95F59A12C1'></acronym>
      <center id='95F59A12C1'><center id='95F59A12C1'><tfoot id='95F59A12C1'></tfoot></center><abbr id='95F59A12C1'><dir id='95F59A12C1'><tfoot id='95F59A12C1'></tfoot><noframes id='95F59A12C1'>

    • <optgroup id='95F59A12C1'><strike id='95F59A12C1'><sup id='95F59A12C1'></sup></strike><code id='95F59A12C1'></code></optgroup>
        1. <b id='95F59A12C1'><label id='95F59A12C1'><select id='95F59A12C1'><dt id='95F59A12C1'><span id='95F59A12C1'></span></dt></select></label></b><u id='95F59A12C1'></u>
          <i id='95F59A12C1'><strike id='95F59A12C1'><tt id='95F59A12C1'><pre id='95F59A12C1'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:297
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          What is STAT's opinion section for?
          What is STAT's opinion section for?

          AdobeThispiecewasadaptedfromarecentFirstOpinionnewsletter.SignuptoreceivetheFirstOpinionnewsletterev

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Ventyx halts psoriasis drug development after lackluster trial results

          AdobeSANDIEGO—VentyxBiosciencesreportedonMondaythatitwasendingdevelopmentofanexperimentaldrugfortrea